Update on global epidemiology of viral hepatitis and preventive strategies
- PMID: 30430114
- PMCID: PMC6232563
- DOI: 10.12998/wjcc.v6.i13.589
Update on global epidemiology of viral hepatitis and preventive strategies
Abstract
Viral hepatitis is one of the major public health concerns around the world but until recently it has drawn little attention or funding from global health policymakers. Every year 1.4 million people die from viral hepatitis-related cirrhosis and liver cancer. However, the majority of the infected population are unaware of their condition. This population have significant obstacles to overcome such as lack of awareness, vulnerability, increased migration, disease stigma, discrimination, as well as poor health resources, conflict in policy development and program implementation. Despite implementing infection control measures over the last few decades eradication or significant disease reduction remains elusive. This study aims to present the current global prevalence status and examines potential elimination strategies. The information for this research were obtained through a systematic review, published scientific literatures, the official websites of various government organisations, international public health organisations and internationally recognised regulatory bodies over a period of 40 years between 1978 and 2018.
Keywords: Cirrhosis; Global epidemiology; Liver cancer; Outreach clinic; Vaccination; Viral hepatitis.
Conflict of interest statement
Conflict-of-interest statement: Nothing to declare.
Figures
References
-
- World Health Organization. Prevention and Control of Viral Hepatitis Infection: Frame Work for Global Action. 2012. Available from: http://www.who.int/hepatitis/publications/Framework/en/
-
- Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013;10:553–562. - PubMed
-
- Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:2212–2219. - PubMed
-
- Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. Hepatitis E. Lancet. 2012;379:2477–2488. - PubMed
-
- Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28:6653–6657. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
